Nuo Therapeutics, Inc. (AURX) financial statements (2022 and earlier)

Company profile

Business Address 209 PERRY PARKWAY,
GAITHERSBURG,, MD 20877
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6376942,62092215,9463,2872,616
Cash and cash equivalents6376942,62092215,9463,2872,616
Restricted cash and investments  545353  
Receivables221142941,0143,2026,3592,824
Inventory, net of allowances, customer advances and progress billings2536702545571,1121,170
Inventory2536702545571,1121,170
Prepaid expense   225729788
Deferred costs    1,091317136
Prepaid expense and other current assets737
Deferred tax assets    (13,751)(3,472)(3,184)
Other current assets     39
Other undisclosed current assets18234233457914,0481,5242,147
Total current assets:8671,1853,3723,04921,8769,9536,447
Noncurrent Assets
Property, plant and equipment1052244861,115925(1,144)(1,375)
Intangible assets, net (including goodwill)  9,9202,51329,87634,89735,264
Goodwill  2,079 1,1291,1291,129
Intangible assets, net (excluding goodwill)  7,8402,51328,74833,76934,135
Deferred costs    3,547482181
Other noncurrent assets315279396  
Other undisclosed noncurrent assets     2,0643,815
Total noncurrent assets:10923910,6854,02534,34836,29937,885
TOTAL ASSETS:9751,42414,0577,07456,22546,25244,331
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:7359371,4476,6639,0808,0192,812
Accounts payable4373803931,0671,8783,3521,434
Accrued liabilities2855571,0552,4536,218  
Employee-related liabilities    984796833
Interest and dividends payable12  3,143   
Other undisclosed accounts payable and accrued liabilities     3,871545
Debt309  35,000 1,800 
Derivative instruments and hedges, liabilities14      
Deferred revenue and credits  524402741 
Customer advances and deposits   2,516
Other undisclosed current liabilities    (3,500)  
Total current liabilities:1,0579371,44742,1878,49810,5602,812
Noncurrent Liabilities
Long-term debt and lease obligation    3263,6212,563
Long-term debt, excluding current maturities    3263,6212,563
Liabilities, other than long-term debt 412394431,4334,690781
Deferred revenue and credits  6371,0391,442 
Other liabilities 4123307547  
Derivative instruments and hedges, liabilities    29,8473,249781
Other undisclosed noncurrent liabilities     570171
Total noncurrent liabilities: 412394431,7598,8813,515
Total liabilities:1,0579411,57143,13240,25719,4406,328
Temporary equity, carrying amount   500500  
Stockholders' equity
Stockholders' equity attributable to parent, including:(82)48312,486(36,558)15,46826,31238,004
Preferred stock000    
Common stock2211212119
Additional paid in capital22,13221,15518,181125,957125,174117,098108,486
Accumulated deficit(22,217)(20,675)(5,696)(162,920)(110,112)(91,229)(70,980)
Other undisclosed stockholders' equity attributable to parent   393393432489
Other undisclosed stockholders' equity     500 
Total stockholders' equity:(82)48312,486(36,558)15,46826,81238,004
TOTAL LIABILITIES AND EQUITY:9751,42414,0577,07456,22546,25244,331

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues1,371721 11,5117,76211,57110,564
Revenue, net721 11,5117,76210,4997,241
Cost of revenue(163)(1,091) (7,967)(6,771)(8,453)(3,915)
Cost of goods and services sold(163)(1,091) (7,967)(6,771)(8,639)(3,915)
Gross profit:1,208(370) 3,5449913,1186,650
Operating expenses(2,712)(15,164) (44,863)(24,382)(21,213)(19,544)
Operating loss:(1,505)(15,534) (41,319)(23,391)(18,095)(12,895)
Nonoperating income (expense)(37)555 (11,578)4,527(2,135)(6,885)
Investment income, nonoperating   29,8478,101(470)492
Other nonoperating income (expense)2566 (11)(7)15(17)
Interest and debt expense(39)(11) (39,313)   
Loss from continuing operations before equity method investments, income taxes:(1,581)(14,990) (92,210)(18,864)(20,230)(19,780)
Other undisclosed income from continuing operations before income taxes3911 39,313   
Loss from continuing operations before income taxes:(1,542)(14,979) (52,897)(18,864)(20,230)(19,780)
Income tax expense (benefit)(405)13,588 89(20)(19)(18)
Net loss:(1,947)(1,391) (52,808)(18,883)(20,248)(19,798)
Other undisclosed net income (loss) attributable to parent405(13,588)     
Net loss attributable to parent:(1,542)(14,979) (52,808)(18,883)(20,248)(19,798)
Preferred stock dividends and other adjustments      (1,513)
Other undisclosed net income available to common stockholders, basic      1,500
Net loss available to common stockholders, diluted:(1,542)(14,979) (52,808)(18,883)(20,248)(19,812)

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(1,947)(1,391) (52,808)(18,883)(20,248)(19,798)
Comprehensive loss, net of tax, attributable to parent:(1,947)(1,391) (52,808)(18,883)(20,248)(19,798)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: